These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21631422)

  • 1. Mechanisms and inhibitors of apoptosis in cardiovascular diseases.
    Singh SS; Kang PM
    Curr Pharm Des; 2011; 17(18):1783-93. PubMed ID: 21631422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and apoptosis in heart dysfunction.
    Kumar D; Lou H; Singal PK
    Herz; 2002 Nov; 27(7):662-8. PubMed ID: 12439637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling Pathways in Cardiac Myocyte Apoptosis.
    Xia P; Liu Y; Cheng Z
    Biomed Res Int; 2016; 2016():9583268. PubMed ID: 28101515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible therapeutic targets in cardiac myocyte apoptosis.
    Andreka P; Nadhazi Z; Muzes G; Szantho G; Vandor L; Konya L; Turner MS; Tulassay Z; Bishopric NH
    Curr Pharm Des; 2004; 10(20):2445-61. PubMed ID: 15320755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and oxidants in the heart.
    Kumar D; Jugdutt BI
    J Lab Clin Med; 2003 Nov; 142(5):288-97. PubMed ID: 14647032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed necrosis in heart disease: Molecular mechanisms and clinical implications.
    Zhu H; Sun A
    J Mol Cell Cardiol; 2018 Mar; 116():125-134. PubMed ID: 29426003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myocardial infarction and heart failure: role of apoptosis.
    Abbate A; Bussani R; Amin MS; Vetrovec GW; Baldi A
    Int J Biochem Cell Biol; 2006; 38(11):1834-40. PubMed ID: 16781883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and heart failure: mechanisms and therapeutic implications.
    Chen QM; Tu VC
    Am J Cardiovasc Drugs; 2002; 2(1):43-57. PubMed ID: 14727998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell death in the pathogenesis of heart disease: mechanisms and significance.
    Whelan RS; Kaplinskiy V; Kitsis RN
    Annu Rev Physiol; 2010; 72():19-44. PubMed ID: 20148665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis in cardiovascular diseases: mechanism and clinical implications.
    Kim NH; Kang PM
    Korean Circ J; 2010 Jul; 40(7):299-305. PubMed ID: 20664736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure.
    Valen G
    Basic Res Cardiol; 2004 Jan; 99(1):1-7. PubMed ID: 14685699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid-mediated signaling systems as novel targets for treatment of heart disease.
    Tappia PS
    Can J Physiol Pharmacol; 2007 Jan; 85(1):25-41. PubMed ID: 17487243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of AIF-mediated caspase-independent programmed cell death.
    Lorenzo HK; Susin SA
    Drug Resist Updat; 2007 Dec; 10(6):235-55. PubMed ID: 18180198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutical perspectives for apoptosis modulation in cardiovascular disease.
    Ginghină C; Crăciunescu I; Iorga V
    Rom J Intern Med; 2006; 44(3):213-22. PubMed ID: 18386601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: From Molecular Mechanisms to Therapeutic Potential.
    Shen Y; Shen Z; Luo S; Guo W; Zhu YZ
    Oxid Med Cell Longev; 2015; 2015():925167. PubMed ID: 26078822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of zinc-bis-(DL-hydrogensaspartate) does not reduce apoptotic cell death in myocardial infarction in the rat heart.
    Schwarz ER; Tussing T; Skobel E; Klosterhalfen B; Domanski D; Fuess JE
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):215-21. PubMed ID: 19605571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure.
    Devalaraja-Narashimha K; Singaravelu K; Padanilam BJ
    Pharmacol Res; 2005 Jul; 52(1):44-59. PubMed ID: 15911333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of caspase-3 inhibitor on the neuronal apoptosis in rat cerebral cortex after ischemia-reperfusion injury].
    Yu SZ; Yan L; Wang Q; An TL; Guan XQ
    Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):165-70. PubMed ID: 16630506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection.
    Barlaka E; Galatou E; Mellidis K; Ravingerova T; Lazou A
    Cardiovasc Ther; 2016 Feb; 34(1):37-48. PubMed ID: 26589375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.